{"transactions":[{"id":744517,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-09T22:40:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares vest and become exercisable as to 100% of the total number of the shares subject to the option on June 3, 2027, subject to the Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":60000,"derivative":{"exercise_price":1.45,"expiration_date":"2036-06-05","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001610717-26-000201","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071726000201/form4.xml","form_type":"4"}},{"id":744516,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-09T22:40:24.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Constitute restricted stock units (\"RSUs\") for which the Reporting Person is entitled to receive one (1) share of Common Stock for each RSU upon vesting.  100% of the RSUs shall vest on the one year anniversary of June 3, 2026, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":30000,"source":{"system":"sec-edgar","filing":"0001610717-26-000201","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071726000201/form4.xml","form_type":"4"}},{"id":774884,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-18T20:42:42.000Z","date":"2026-05-15","kind":"purchase","planned":false,"acquired":true,"shares":60000,"price":2.53,"value":151800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.52 to $2.56 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":147555,"source":{"system":"sec-edgar","filing":"0001628280-26-035996","document":"wk-form4_1779136958.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035996/wk-form4_1779136958.xml","form_type":"4"}},{"id":776968,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":75204,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":276149,"derivative":{"exercise_price":2.52,"expiration_date":"2036-05-13","underlying":"Common Stock","underlying_shares":75204},"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":776967,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":34226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of restricted stock units (the \"Retainer RSU Award\") payable solely in common stock of the Issuer. The Reporting Person elected to receive the Retainer RSU Award in lieu of 2026 board service retainer cash fees provided for under the Issuer's Non-Employee Director Compensation Policy. The shares subject to the Retainer RSU Award shall vest quarterly in equal one-third installments through the remainder of 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":87555,"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":776966,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-15T20:39:26.000Z","date":"2026-05-14","kind":"grant","planned":false,"acquired":true,"shares":37602,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units (the \"RSU Award\") payable solely in common stock of the Issuer. The shares subject to the RSU award shall fully vest on the one-year anniversary of the grant date of May 14, 2026, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":53329,"source":{"system":"sec-edgar","filing":"0001628280-26-035667","document":"wk-form4_1778877563.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000162828026035667/wk-form4_1778877563.xml","form_type":"4"}},{"id":1100139,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2025-06-27T20:12:27.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of June 12, 2025, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":200945,"derivative":{"exercise_price":5.5,"expiration_date":"2035-06-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001826667-25-000079","document":"wk-form4_1751055139.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000182666725000079/wk-form4_1751055139.xml","form_type":"4"}},{"id":1111496,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-13T22:49:51.000Z","date":"2025-06-12","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 11, 2025, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":0.7904,"expiration_date":"2035-06-12","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-25-000227","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071725000227/form4.xml","form_type":"4"}},{"id":1131791,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-28T21:12:50.000Z","date":"2025-05-23","kind":"sale","planned":false,"acquired":false,"shares":99988,"price":0.7389,"value":73881.1332,"ownership":{"direct":false,"nature":"Leonard Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported sale transactions were effected for tax planning purposes."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.7362 to $0.7448, exclusive of any fees, commissions or other expenses. The Reporting Person undertakes to provide to Coherus BioSciences, Inc., any security holder of Coherus BioSciences, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-25-000145","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071725000145/form4.xml","form_type":"4"}},{"id":1273755,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2025-02-11T22:59:14.000Z","date":"2025-02-10","kind":"other","planned":false,"acquired":true,"shares":44750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Leonard Capital LLC"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The conversion price (the \"Conversion Price\") reflects the reset effective as of February 10, 2025, which reset occurred in accordance with the terms of the Issuer's Certificate of Designations, Preferences and Rights of Series A Convertible Preferred Stock of the Issuer filed with the Delaware Secretary of State on August 10, 2023."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Effective February 10, 2025, the Conversion Price of the 50,000 shares of Series A Convertible Preferred Stock (the \"Preferred Stock\") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock."},{"field":"shares","element":"transactionShares","label":"F2","text":"Effective February 10, 2025, the Conversion Price of the 50,000 shares of Series A Convertible Preferred Stock (the \"Preferred Stock\") held by the Reporting Person was reset in accordance with the terms of the Preferred Stock, resulting in an increase in the number of shares of Common Stock issuable upon conversion of the Preferred Stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 94,750 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"All then outstanding shares of Preferred Stock are automatically converted into shares of the Issuer's Common Stock on August 10, 2027."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"Represents the incremental number of shares of Common Stock that are issuable upon conversion of the Preferred Stock as a result of the Conversion Price reset."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"After giving effect to the Conversion Price reset, the Preferred Stock is convertible, in whole or in part, into 94,750 shares of Common Stock of the Issuer (based on a Conversion Price of $5.277 per share, which is subject to adjustment upon the occurrence of certain events) at any time, at the Reporting Person's election."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"The Reporting Person shares voting and investment discretion with his spouse with respect to the shares held directly by Leonard Capital LLC."}],"balance_after":94750,"derivative":{"exercise_price":5.277,"underlying":"Common Stock","underlying_shares":44750},"source":{"system":"sec-edgar","filing":"0001415889-25-003621","document":"form4-02112025_100210.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588925003621/form4-02112025_100210.xml","form_type":"4"}},{"id":1325290,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-12-19T23:07:25.000Z","date":"2024-12-17","kind":"grant","planned":false,"acquired":true,"shares":25188,"price":3.97,"value":99996.36,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares were issued in connection with the closing of the transaction contemplated by the Securities Purchase Agreement, entered into December 12, 2024, by and between the Issuer and Reporting Person."}],"balance_after":40915,"source":{"system":"sec-edgar","filing":"0001415889-24-029907","document":"form4-12192024_111222.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588924029907/form4-12192024_111222.xml","form_type":"4"}},{"id":1352607,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-25T22:53:03.000Z","date":"2024-11-22","kind":"purchase","planned":false,"acquired":true,"shares":5000,"price":4.55,"value":22750.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.45 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":15727,"source":{"system":"sec-edgar","filing":"0001415889-24-027656","document":"form4-11252024_101159.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588924027656/form4-11252024_101159.xml","form_type":"4"}},{"id":1354167,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-23T00:11:22.000Z","date":"2024-11-21","kind":"purchase","planned":false,"acquired":true,"shares":8687,"price":4.44,"value":38570.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.19 to $4.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":10727,"source":{"system":"sec-edgar","filing":"0001415889-24-027587","document":"form4-11232024_121118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588924027587/form4-11232024_121118.xml","form_type":"4"}},{"id":1354166,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2024-11-23T00:11:22.000Z","date":"2024-11-20","kind":"purchase","planned":false,"acquired":true,"shares":2040,"price":4.16,"value":8486.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were purchased in multiple transactions at prices ranging from $3.99 to $4.29, inclusive.  The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range."}],"balance_after":2040,"source":{"system":"sec-edgar","filing":"0001415889-24-027587","document":"form4-11232024_121118.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588924027587/form4-11232024_121118.xml","form_type":"4"}},{"id":1426469,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Director stock option (right to buy)","published_at":"2024-08-22T00:48:30.000Z","date":"2024-08-13","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall fully vest on the one-year anniversary of the grant date of August 13, 2024, provided that the shares subject to the option will in any case be fully vested on the date of the Issuer's next annual stockholder meeting, subject to the Reporting Person's continued service with the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":5.75,"expiration_date":"2034-08-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-24-021962","document":"form4-08222024_120827.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000141588924021962/form4-08222024_120827.xml","form_type":"4"}},{"id":1489923,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-05T22:50:22.000Z","date":"2024-06-03","kind":"grant","planned":false,"acquired":true,"shares":112000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 100% of the total number of shares subject to the option on the one year anniversary of June 3, 2024, subject to Reporting Person's continued service relationship with the Issuer on such vesting date."}],"balance_after":112000,"derivative":{"exercise_price":1.76,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":112000},"source":{"system":"sec-edgar","filing":"0001610717-24-000290","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000290/form4.xml","form_type":"4"}},{"id":1640895,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-16T00:56:46.000Z","date":"2024-02-09","kind":"gift","planned":false,"acquired":true,"shares":99988,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"Leonard Capital, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person and his spouse are the members of Leonard Capital, LLC and therefore the Reporting Person may be deemed to have voting and dispositive power of shares held by Leonard Capital, LLC."}],"balance_after":99988,"source":{"system":"sec-edgar","filing":"0001610717-24-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000060/form4.xml","form_type":"4"}},{"id":1640894,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-16T00:56:46.000Z","date":"2024-02-09","kind":"gift","planned":false,"acquired":false,"shares":99988,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects the transfer, for no consideration, of 99,988 shares directly owned by the Reporting Person to Leonard Capital, LLC."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001610717-24-000060","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000060/form4.xml","form_type":"4"}},{"id":1658675,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":44991,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.667,"expiration_date":"2024-03-10","underlying":"Common Stock","underlying_shares":44991},"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658674,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":false,"shares":14997,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.667,"expiration_date":"2024-03-10","underlying":"Common Stock","underlying_shares":14997},"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658673,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":44991,"price":1.667,"value":74999.997,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price."}],"balance_after":99988,"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1658672,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-02-06T00:03:30.000Z","date":"2024-02-01","kind":"exercise","planned":false,"acquired":true,"shares":14997,"price":1.667,"value":24999.999,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents a cash exercise-and-hold transaction where cash was paid by the Reporting Person for the exercise price."}],"balance_after":54997,"source":{"system":"sec-edgar","filing":"0001610717-24-000044","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071724000044/form4.xml","form_type":"4"}},{"id":1808484,"issuer":{"id":5872,"kind":"organization","name":"TriSalus Life Sciences, Inc.","symbol":"TLSI"},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-08-14T22:19:52.000Z","date":"2023-08-10","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this stock option vest in three equal annual installments from the vesting commencement date of August 10, 2023, subject to the Reporting Person's continued service with the Issuer on each respective vesting date."}],"balance_after":35000,"derivative":{"exercise_price":11.34,"expiration_date":"2033-08-09","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0001209191-23-045700","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000120919123045700/doc4.xml","form_type":"4"}},{"id":1860423,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-09T21:09:44.000Z","date":"2023-06-07","kind":"grant","planned":false,"acquired":true,"shares":38250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from June 7, 2023, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":38250,"derivative":{"exercise_price":5.38,"expiration_date":"2033-06-07","underlying":"Common Stock","underlying_shares":38250},"source":{"system":"sec-edgar","filing":"0001610717-23-000122","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000161071723000122/form4.xml","form_type":"4"}},{"id":2365138,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-03-02T01:22:07.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":29994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option are fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":2.0838,"expiration_date":"2022-12-14","underlying":"Common Stock","underlying_shares":29994},"source":{"system":"sec-edgar","filing":"0001567619-22-005922","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761922005922/doc1.xml","form_type":"4"}},{"id":2365137,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-02T01:22:07.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":29994,"price":2.0838,"value":62501.4972,"ownership":{"direct":true},"balance_after":40000,"source":{"system":"sec-edgar","filing":"0001567619-22-005922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761922005922/doc1.xml","form_type":"4"}},{"id":2365136,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-03-02T01:22:07.000Z","date":"2022-02-25","kind":"grant","acquired":true,"shares":10006,"price":11.6363,"value":116432.8178,"ownership":{"direct":true},"balance_after":10006,"source":{"system":"sec-edgar","filing":"0001567619-22-005922","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761922005922/doc1.xml","form_type":"4"}},{"id":2401608,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-11T21:11:41.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Form 4/A is being filed solely to correct a typographical error in the exercise price. Except as noted in this footnote, all other information as disclosed in the Reporting Person's original Form 4 was accurately reported."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":27000,"derivative":{"exercise_price":14.67,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001567619-22-003502","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761922003502/doc1.xml","form_type":"4/A","original_submission_date":"2022-01-10"}},{"id":2438874,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-10T21:30:21.000Z","date":"2022-01-07","kind":"grant","acquired":true,"shares":27000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2022, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":27000,"derivative":{"exercise_price":15.94,"expiration_date":"2032-01-07","underlying":"Common Stock","underlying_shares":27000},"source":{"system":"sec-edgar","filing":"0001567619-22-000920","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761922000920/doc1.xml","form_type":"4"}},{"id":2908169,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-13T21:31:10.000Z","date":"2021-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2021, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.58,"expiration_date":"2031-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-21-000990","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761921000990/doc1.xml","form_type":"4"}},{"id":3104247,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-06-19T20:33:28.000Z","date":"2020-06-17","kind":"sale","acquired":false,"shares":200000,"price":17.1501,"value":3430020.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $17.00 to $17.3750, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-20-012456","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761920012456/doc1.xml","form_type":"4"}},{"id":3224475,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-05T21:31:46.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":4222,"price":20.8941,"value":88214.8902,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $20.50 to $21.06, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001567619-20-005741","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761920005741/doc1.xml","form_type":"4"}},{"id":3224474,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2020-03-05T21:31:46.000Z","date":"2020-03-03","kind":"sale","acquired":false,"shares":113844,"price":20.0906,"value":2287194.2664,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $19.50 to $20.30, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Leonard Capital, LLC. Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":204222,"source":{"system":"sec-edgar","filing":"0001567619-20-005741","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761920005741/doc1.xml","form_type":"4"}},{"id":3311581,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-14T22:54:06.000Z","date":"2020-01-10","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 1, 2020, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":17.73,"expiration_date":"2030-01-10","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001567619-20-001046","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761920001046/doc1.xml","form_type":"4"}},{"id":3502245,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-04T21:39:19.000Z","date":"2019-05-31","kind":"other","acquired":true,"shares":98152,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"KMG Capital Partners, LLC distributed an aggregate of 178,528 shares of common stock of the issuer to its limited and general partners for no consideration, effective May 31, 2019.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Leonard Capital, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":318066,"source":{"system":"sec-edgar","filing":"0001567619-19-012731","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761919012731/doc1.xml","form_type":"4"}},{"id":3502244,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2019-06-04T21:39:19.000Z","date":"2019-05-31","kind":"other","acquired":false,"shares":178528,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"KMG Capital Partners, LLC distributed an aggregate of 178,528 shares of common stock of the issuer to its limited and general partners for no consideration, effective May 31, 2019.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by KMG Capital Partners, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-19-012731","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000156761919012731/doc1.xml","form_type":"4"}},{"id":3682593,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-30T21:06:05.000Z","date":"2019-01-11","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from January 11, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":12.37,"expiration_date":"2029-01-11","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-19-002188","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924319002188/doc4.xml","form_type":"4"}},{"id":4076247,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-02-05T21:05:28.000Z","date":"2018-02-01","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from February 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":10.05,"expiration_date":"2028-02-01","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-18-002881","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924318002881/doc4.xml","form_type":"4"}},{"id":4311654,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-19T20:05:22.000Z","date":"2017-05-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The underlying shares subject to the option vest and become exercisable as to 1/12th of the total number of shares subject to the option in successive, equal monthly installments measured from May 17, 2017, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date."}],"balance_after":20000,"derivative":{"exercise_price":23.8,"expiration_date":"2027-05-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0000899243-17-013888","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924317013888/doc4.xml","form_type":"4"}},{"id":4311653,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-19T20:05:22.000Z","date":"2017-05-09","kind":"other","acquired":true,"shares":109957,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Leonard Capital, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":219914,"source":{"system":"sec-edgar","filing":"0000899243-17-013888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924317013888/doc4.xml","form_type":"4"}},{"id":4311652,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-19T20:05:22.000Z","date":"2017-05-09","kind":"other","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on April 27, 2017.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by KMG Capital Partners, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein."}],"balance_after":178528,"source":{"system":"sec-edgar","filing":"0000899243-17-013888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924317013888/doc4.xml","form_type":"4"}},{"id":4311651,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-19T20:05:22.000Z","date":"2017-02-22","kind":"other","acquired":true,"shares":109957,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The shares are held by Leonard Capital, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":109957,"source":{"system":"sec-edgar","filing":"0000899243-17-013888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924317013888/doc4.xml","form_type":"4"}},{"id":4311650,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2017-05-19T20:05:22.000Z","date":"2017-02-22","kind":"other","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"KMG Capital Partners, LLC distributed an aggregate of 200,000 shares of common stock of the issuer to its limited and general partners for no consideration on February 22, 2017.  Reflects pro rata allocation of such shares distributed to Leonard Capital, LLC."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by KMG Capital Partners, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by KMG Capital Partners, LLC except to the extent of his pecuniary interest therein."}],"balance_after":378528,"source":{"system":"sec-edgar","filing":"0000899243-17-013888","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924317013888/doc4.xml","form_type":"4"}},{"id":4527127,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-09T21:05:36.000Z","date":"2016-12-08","kind":"sale","acquired":false,"shares":46190,"price":27.5243,"value":1271347.417,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $27.65, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Leonard Capital, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-16-035219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924316035219/doc4.xml","form_type":"4"}},{"id":4527126,"issuer":{"id":6276,"kind":"organization","name":"Coherus Oncology, Inc."},"owners":[{"id":40019,"kind":"person","name":"Wahlstrom Mats","position":1,"cik":"0001459154","reported_name":"Wahlstrom Mats","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2016-12-09T21:05:36.000Z","date":"2016-12-07","kind":"sale","acquired":false,"shares":7393,"price":27.503,"value":203329.679,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The transaction was executed in multiple trades in prices ranging from $27.50 to $27.55, inclusive.  The price reported in Column 4 above reflects the weighted average sale price.  The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The shares are held by Leonard Capital, LLC.  Mr. Wahlstrom disclaims beneficial ownership of the shares held by Leonard Capital, LLC except to the extent of his pecuniary interest therein."}],"balance_after":46190,"source":{"system":"sec-edgar","filing":"0000899243-16-035219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1459154/000089924316035219/doc4.xml","form_type":"4"}}]}